The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study

Maturitas

Volumn 81, Issue 3, 2015, Pages 384-388

  Tuomikoski, Pauliina ^a   Lyytinen, Heli ^a   Korhonen, Pasi ^b   Hoti, Fabian ^b   Vattulainen, Pia ^b   Gissler, Mika ^c,d   Ylikorkala, Olavi ^a   Mikkola, Tomi S ^a,e  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b EPID Research Oy   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^e FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

Cardiovascular disease; Estradiol; Menopause; Mortality

Indexed keywords

ESTRADIOL;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DEATH; FEMALE; FINLAND; FINN (CITIZEN); FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; POSTMENOPAUSE; REGISTER; RETROSPECTIVE STUDY; RISK; RISK REDUCTION; STANDARDIZED MORTALITY RATIO; WOMEN'S HEALTH; EPIDEMIOLOGY; ESTROGEN THERAPY; MORTALITY; PROTECTION; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ESTROGEN REPLACEMENT THERAPY; FEMALE; FINLAND; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROTECTIVE FACTORS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84931561516     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.04.002     Document Type: Article

References (35)

1. V.L. Feigin, M.H. Forouzanfar, and R. Krishnamurthi Global and regional burden of stroke during 1990-2010: findings from the global burden of disease study 2010 Lancet 383 2014 245 254
2. C. Bushnell, L.D. McCullough, and I.A. Awad Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 45 2014 1545 1588
3. J. Marjoribanks, C. Farquhar, and H. Roberts Long term hormone therapy for perimenopausal and postmenopausal women Cochrane Database Syst Rev 7 2012 CD004143
4. V. Stearns, L. Ullmer, and J. Lopéz Hot flushes Lancet 360 2002 1851 1861
5. A. Paganini-Hill Hormone replacement therapy and stroke: risk, protection or no effect? Maturitas 38 2001 243 261
6. F. Grodstein, J.E. Manson, and M.J. Stampfer Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy Arch Intern Med 168 2008 861 866
7. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
8. J.E. Rossouw, R.L. Prentice, and J.E. Manson Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause JAMA 297 2007 1465 1477
9. N. Cherry, R. McNamee, and A. Heagerty Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14-year follow-up of the ESPRIT randomised controlled trial BJOG 121 2014 700 705
10. H. Gu, X. Zhao, and X. Zhao Risk of stroke in healthy postmenopausal women during and after hormone therapy: a meta-analysis Menopause 21 Nov 2014 1204 1210 http://dx.doi.org/10.1097/GME.0000000000000227
11. C.M. Viscoli, L.M. Brass, and W.N. Kernan A clinical trial of estrogen-replacement therapy after ischemic stroke NEJM 345 2001 1243 1249
12. C.L. Shufelt, C.N. Merz, and R.L. Prentice Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the women's health initiative observational study Menopause 21 2014 260 266
13. European Cardiovascular Disease Statistics, 2012 edition, http://www.ehnheart.org/cvd-statistics.html.
14. American College of Physicians Guidelines for counseling postmenopausal women about preventive hormone therapy Ann Intern Med 117 1992 1038 1041
15. Clinical challenges of perimenopause: consensus opinion of The North American Menopause Society. http://www.menopause.org/docs/default-document-library/psperimenopause00.pdf?sfvrsn=2.
16. P. Tuomikoski, H. Lyytinen, and P. Korhonen Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative Obstet Gynecol 124 2014 947 953
17. E. Vartiainen, T. Laatikainen, and M. Peltonen Thirty-five-year trends in cardiovascular risk factors in Finland Int J Epidemiol 39 2010 504 518
18. J.M. Rapola, J. Virtamo, and P. Korhonen Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland Eur J Epidemiol 13 1997 133 138
19. A. Meretoja, M. Kaste, and R.O. Roine Trends in treatment and outcome of stroke patients in Finland from 1999 to 2007. PERFECT stroke, a nationwide register study Ann Med 43 Suppl 1 2011 S22 S30
20. A.S. Go, D. Mozaffarian, and V.L. Roger Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e280 e292
21. G.L. Anderson, M. Limacher, and A.R. Assaf Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial JAMA 291 2004 1701 1712
22. A. Hsu, A. Card, and S.X. Lin Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk Am J Public Health 99 2009 2184 2187
23. A. Fournier, C. Kernaleguen, and H. Panjo Postmenopausal hormone therapy initiation before and after the women's health initiative in two French cohorts Menopause 18 2011 219 223
24. A.W. Taylor, A.H. MacLennan, and J.C. Avery Postmenopausal hormone therapy: who now takes it and do they differ from non-users? Aust N Z J Obstet Gynaecol 46 2006 128 135
25. R.J. Santen, D.C. Allred, and S.P. Ardoin Postmenopausal hormone therapy: an endocrine society scientific statement J Clin Endocrinol Metab 95 2010 s1 s66
26. The North American Menopause Society The 2012 hormone therapy position statement of the North American Menopause Society Menopause 19 2012 257 271
27. V.W. Henderson, and R.A. Lobo Hormone therapy and the risk of stroke: perspectives 10 years after the women's health initiative trials Climacteric 15 2012 229 234
28. J. Addo, L. Ayerbe, and K.M. Mohan Socioeconomic status and stroke: an updated review Stroke 43 2012 1186 1191
29. P. Topo, R. Luoto, and E. Hemminki Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland Maturitas 32 1999 141 145
30. N.L. Smith, M. Blondon, and K.L. Wiggins Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens JAMA Intern Med 174 2014 25 31
31. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 1998 605 613 (Heart and Estrogen/progestin Replacement Study (HERS) Research Group)
32. J.E. Manson, R.T. Chlebowski, and M.L. Stefanick Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials JAMA 310 2013 1353 1368
33. L.L. Schierbeck, L. Rejnmark, and C.L. Tofteng Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial BMJ 345 2012 e6409
34. H. Schunkert, I.R. Konig, and S. Kathiresan Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Nat Genet 43 2011 333 338
35. T.A. Koivu, Y.M. Fan, and K.M. Mattila The effect of hormone replacement therapy on atherosclerotic severity in relation to ESR1 genotype in postmenopausal women Maturitas 44 2003 29 38